After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NYSE-listed company operates within the Drug Manufacturers – General industry segment, falling under the Healthcare sector. The current market capitalization of Johnson & Johnson is $529.01B. A total of 8.4 million shares were traded on the day, compared to an average of 8.51M shares.
In the most recent transaction, MORIKIS JOHN G bought 1,250 shares of JNJ for 206.15 per share on Nov 26 ’25. After the transaction, the Director now owns 1,849 company shares. In a previous transaction on Nov 26 ’25, JOHNSON & JOHNSON sold 6,337 shares at 10.03 per share. JNJ shares that 10% Owner owns now total 4,040,861.
Among the insiders who sold shares, JOHNSON & JOHNSON disposed of 2,200 shares on Nov 24 ’25 at a per-share price of $10.06. This resulted in the 10% Owner holding 4,047,198 shares of JNJ after the transaction. In another insider transaction, JOHNSON & JOHNSON sold 500 shares at $10.00 per share on Nov 21 ’25. Company shares held by the 10% Owner now total 4,049,398.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Johnson & Johnson pays an annual dividend of $5.14, resulting in a dividend yield of 2.34%, and it has a price to earnings (P/E) ratio of 21.19.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, JNJ has a high of $218.86 and a low of $141.50.
As of this writing, JNJ has an earnings estimate of $2.48 per share for the current quarter. EPS was calculated based on a consensus of 20.0 estimates, with a high estimate of $2.57 per share and a lower estimate of $2.37. The company reported an EPS of $2.04 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. JNJ’s latest balance sheet shows that the firm has $31.61B in Cash & Short Term Investments as of fiscal 2021. There were $33.75B in debt and $45.23B in liabilities at the time. Its Book Value Per Share was $32.95, while its Total Shareholder’s Equity was $74.02B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
